The Therapeutic Goods Administration says the benefits of the AstraZeneca vaccine far outweigh the risks after a NSW woman died from a blood clot in the brain.

The Therapeutic Goods Administration says the benefits of the AstraZeneca vaccine far outweigh the risks after a NSW woman died from a blood clot in the brain.